Higgins, S. T., Nighbor, T. D., Kurti, A. N., Heil, S. H., Slade, E. P., Shepard, D. S., Solomon, L. J., Lynch, M. E., Johnson, H. K., Markesich, C., Rippberger, P. L., Skelly, J. M., DeSarno, M., Bunn, J., Hammond, J. B., Roemhildt, M. L., Williams, R. K., O'Reilly, D. M., & Bernstein, I. M. (2022). Randomized Controlled Trial Examining the Efficacy of Adding Financial Incentives to Best practices for Smoking Cessation Among pregnant and Newly postpartum Women. Preventive medicine, 165(Pt B), 107012. https://doi.org/10.1016/j.ypmed.2022.107012 Evidence Rating: Scientifically Rigorous Intervention Components (click on component to see a list of all articles that use that intervention): Incentives, , PATIENT_CONSUMER Intervention Description: We report results from a single-blinded randomized controlled trial examining financial incentives for smoking cessation among 249 pregnant and newly postpartum women. Intervention Results: Compared to BP, BP + FI significantly increased abstinence early- (AOR = 9.97; 95%CI, 3.32‐29.93) and late-pregnancy (primary outcome, AOR = 5.61; 95%CI, 2.37‐13.28) and through 12-weeks postpartum (AOR = 2.46; CI,1.05‐5.75) although not 24- (AOR = 1.31; CI,0.54‐3.17) or 48-weeks postpartum (AOR = 1.33; CI,0.55‐3.25). There was a significant effect of trial condition on small-for-gestational-age (SGA) deliveries (χ2 [2] = 9.01, P = .01), with percent SGA deliveries (+SEM) greatest in BP, intermediate in BP + FI, and lowest in NS (17.65 + 4.13, 10.81 + 3.61, and 2.53 + 1.77, respectively). Reliability analyses supported the efficacy of financial incentives for increasing abstinence antepartum and postpartum and decreasing SGA deliveries; external-validity analyses supported relationships between antepartum cessation and SGA risk. Conclusion: Adding financial incentives to Best Practice increases smoking cessation among antepartum and postpartum women and improves other maternal-infant outcomes. Access AbstractShow More
|